Xiao-jian Yan
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors.
Journal: Signal transduction and targeted therapy
Published: October 01, 2022
Management of pelvic organ prolapse of ruptured and extruded bladder from a rare complication of vaginal hysterectomy: a case presentation.
Journal: BMC surgery
Published: September 02, 2020
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer.
Journal: Frontiers in oncology
Published: November 01, 2019
Survivin Promotes Piperlongumine Resistance in Ovarian Cancer.
Journal: Frontiers in oncology
Published: September 27, 2019
Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo.
Journal: Frontiers in oncology
Published: December 06, 2018
YM155 enhances docetaxel efficacy in ovarian cancer.
Journal: American journal of translational research
Published: September 22, 2017
Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer.
Journal: American journal of translational research
Published: October 13, 2016
Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer.
Journal: American journal of cancer research
Published: October 20, 2015
Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells.
Journal: Oxidative medicine and cellular longevity
Published: February 14, 2014
Triterpenoids as reversal agents for anticancer drug resistance treatment.
Journal: Drug discovery today
Published: May 11, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026